Skip to Content

New Drug Approvals Archive - February 2003

February 2003

Cardizem LA (diltiazem hydrochloride) Extended-Release Tablets

Date of Approval: February 6, 2003
Company: Biovail Laboratories Incorporated
Treatment for: Hypertension, Angina Pectoris

Cardizem LA is an extended-release formulation of diltiazem for indicated for the once-daily treatment of hypertension and for the management of chronic stable angina.

Oxytrol (oxybutynin) Transdermal System

Date of Approval: February 26, 2003
Company: Allergan, Inc.
Treatment for: Overactive Bladder

Oxytrol (oxybutynin) is a transdermal therapy used to treat overactive bladder (OAB), with symptoms of urge urinary incontinence, urgency and frequency.

Cardizem LA (diltiazem hydrochloride)

New Indication Approved: April 2, 2004

New Drug Approvals Archive

More News Resources

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.